🏛️ Verified NIH Record • Updated 2025-06-17

US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus (NCT05232838)

US Pilot Study to Evaluate the Safety and Effectiveness of the CereVasc® eShunt® System in the Treatment of Normal Pressure Hydrocephalus

🔵 Active, Not Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: CereVasc Inc

🩺 Plain-English Summary (8th-Grade Level)

The eShunt® System is a minimally invasive method of treating communicating hydrocephalus. The eShunt System includes a proprietary eShunt Delivery System and the eShunt Implant, a permanent implant deployed in a minimally invasive, neuro-interventional procedure. The eShunt System is intended to shunt cerebrospinal fluid from the intracranial subarachnoid space to the venous system for the treatment of patients with normal pressure hydrocephalus, reducing disability due to symptoms including one or more of gait disturbance, cognitive dysfunction and urinary incontinence.

Who can join: Review the eligibility criteria below.

Location: Yale University — New Haven, Connecticut

Age range: 65 Years to 85 Years

🧪 Interventions in This Study

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (11 Sites)

  • Yale University — New Haven, Connecticut
  • Baptist Health — Jacksonville, Florida
  • University of Kansas Medical Center — Kansas City, Kansas
  • University of Kentucky Research Foundation — Lexington, Kentucky
  • Beth Israel Deaconess Medical Center — Boston, Massachusetts
  • University at Buffalo, — Buffalo, New York
  • NYU Langone Health — New York, New York
  • University of Rochester Medical Center — Rochester, New York
  • Montefiore Medical Center — The Bronx, New York
  • Rhode Island Hospital — Providence, Rhode Island
  • Virginia Commonwealth University — Richmond, Virginia

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗